Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.

Dylan B Ness,Darcy B Pooler, Steven Ades, Brian J Highhouse, Bridget M Labrie, Jie Zhou,Jiang Gui,Lionel D Lewis,Marc S Ernstoff

Cancer medicine（2023）

Cited 1|Views14
No score
Abstract
Alternating sunitinib and temsirolimus did not improve the PFS in patients with mRCC.
More
Translated text
Key words
renal cell carcinoma,temsirolimus therapy,sunitinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined